Creative Planning Arcturus Therapeutics Holdings Inc. Transaction History

Creative Planning

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$25.79 - $42.11 $1.17 Million - $1.9 Million	-45,237 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$38.75 - $86.92 $39,098 - $87,702	1,009 Added 2.28%	45,237 $1.87 Million
Q4 2020 Jan 29, 2021	SELL	$34.61 - $123.66 $1,038 - $3,709	-30 Reduced 0.07%	44,228 $1.92 Million
Q3 2020 Nov 05, 2020	BUY	$37.49 - $63.19 $73,780 - $124,357	1,968 Added 4.65%	44,258 $1.9 Million
Q2 2020 Jul 23, 2020	SELL	$12.66 - $58.27 $164,048 - $755,062	-12,958 Reduced 23.45%	42,290 $1.98 Million
Q1 2020 May 05, 2020	SELL	$9.31 - $18.26 $53,281 - $104,501	-5,723 Reduced 9.39%	55,248 $751,000
Q2 2019 Jul 26, 2019	BUY	$5.78 - $9.79 $352,412 - $596,906	60,971 New	60,971 $576,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $450M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.